Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn Henry

Showing results (111-120 of 195) with videos related to

Pageof 20
Sort By:
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|April 29, 2017
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitorsKunal C Kadakia, Kelley M Kidwell, Nicholas J Seewald, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Breast Cancer Research and Treatment|June 3, 2025
A mixed-methods study characterizing experiences of medical oncologists' use of gonadotropin-releasing hormone agonists for treatment of breast cancerKimberley T Lee, Bihe Hu, Dinorah Martinez Tyson, et al.
Frontiers in Genetics|July 2, 2021
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast CancerDaniel L Hertz, Karen Lisa Smith, Yuhua Zong, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Current Oncology (Toronto, Ont.)|February 13, 2021
Integrative Oncology Education: An Emerging Competency for Oncology ProvidersSafiya Karim, Rita Benn, Linda E Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2011
Cytoplasmic estrogen receptor in breast cancerAllison W Welsh, Donald R Lannin, Gregory S Young, et al.
Molecular Oncology|August 16, 2015
Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analysesDaniel L Hertz, Kelley M Kidwell, Jacklyn N Thibert, et al.
Pageof 20

Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|April 29, 2017
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitorsKunal C Kadakia, Kelley M Kidwell, Nicholas J Seewald, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Breast Cancer Research and Treatment|June 3, 2025
A mixed-methods study characterizing experiences of medical oncologists' use of gonadotropin-releasing hormone agonists for treatment of breast cancerKimberley T Lee, Bihe Hu, Dinorah Martinez Tyson, et al.
Frontiers in Genetics|July 2, 2021
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast CancerDaniel L Hertz, Karen Lisa Smith, Yuhua Zong, et al.
Breast Cancer Research and Treatment|February 15, 2016
Clinical predictors of long-term survival in HER2-positive metastatic breast cancerPooja Murthy, Kelley M Kidwell, Anne F Schott, et al.
Current Oncology (Toronto, Ont.)|February 13, 2021
Integrative Oncology Education: An Emerging Competency for Oncology ProvidersSafiya Karim, Rita Benn, Linda E Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2011
Cytoplasmic estrogen receptor in breast cancerAllison W Welsh, Donald R Lannin, Gregory S Young, et al.
Molecular Oncology|August 16, 2015
Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analysesDaniel L Hertz, Kelley M Kidwell, Jacklyn N Thibert, et al.
Pageof 20